Interventional and structural cardiology

The interventional cardiology researchers have a strong focus on leading edged worldwide first-in-man Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve and Mitral Clip Implantation, InterAtrial Shunt device and Percutaneous Coronary Intervention Stent clinical trials which paved the way for a number of these devices to be approved by the Therapeutics Goods Administration for commercial use as part of standard of care procedures.

The tremendous development in valves, delivery systems and technical approaches in the last 15 years provided our clinicians opportunity and experience to adapt the new technologies. The devices also led to breakthrough lifesaving treatment to hundreds of patients with cardiovascular conditions such as but not limited to severe aortic stenosis, severe mitral regurgitation, heart failure and acute coronary syndrome.

Clinical Characteristics and Outcomes of STEMI for Primary PCI – An Australian/Indian Comparison

Lead Investigator: Michael Savage

Comparison of population demographics, procedural characteristics, times to reperfusion and mortality in ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI) between two tertiary referral centers in India and Australia respectively.

Pre-hospital Activation and direct transfer of STEMI for Primary PCI – Insights from the Queensland Cardiac Outcomes Registry

Lead Investigator: Michael Savage

Assessment of the association of pre-hospital ambulance activation of the catheter laboratory on mortality and ST-segment elevation myocardial infarction (STEMI) performance measures in STEMI patients treated with percutaneous coronary intervention (PCI) from the Queensland Cardiac Outcomes Registry (QCOR).

Sex Differences in Time to Primary Percutaneous Coronary Intervention and Outcomes in patients presenting with ST Segment Elevation Myocardial Infarction

Lead Investigator: Michael Savage

Assessing sex differences in treatment and outcomes in ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI) over a 10-year period.